A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism

BackgroundThe diagnosis of congenital hyperinsulinism (CHI) may be hampered by a plasma (p-) insulin detection limit of 12–18 pmol/L (2–3 mU/L).ObjectiveTo evaluate the diagnostic performance of a sensitive insulin immunoassay and to find the optimal p-insulin cut-off for the diagnosis of CHI.Method...

Full description

Bibliographic Details
Main Authors: Julie Siersbæk, Annette Rønholt Larsen, Mads Nybo, Henrik Thybo Christesen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2020.614993/full
id doaj-54a946bccc804a0aa5bdef92ae67117d
record_format Article
spelling doaj-54a946bccc804a0aa5bdef92ae67117d2021-02-19T06:46:37ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-02-011110.3389/fendo.2020.614993614993A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital HyperinsulinismJulie Siersbæk0Julie Siersbæk1Annette Rønholt Larsen2Annette Rønholt Larsen3Mads Nybo4Henrik Thybo Christesen5Henrik Thybo Christesen6Henrik Thybo Christesen7Hans Christian Andersen Children’s Hospital, Odense University Hospital, Odense, DenmarkDepartment of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, DenmarkHans Christian Andersen Children’s Hospital, Odense University Hospital, Odense, DenmarkDepartment of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, DenmarkDepartment of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, DenmarkHans Christian Andersen Children’s Hospital, Odense University Hospital, Odense, DenmarkDepartment of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, DenmarkOdense Pancreas Center (OPAC), Odense University Hospital, Odense, DenmarkBackgroundThe diagnosis of congenital hyperinsulinism (CHI) may be hampered by a plasma (p-) insulin detection limit of 12–18 pmol/L (2–3 mU/L).ObjectiveTo evaluate the diagnostic performance of a sensitive insulin immunoassay and to find the optimal p-insulin cut-off for the diagnosis of CHI.MethodsDiagnostic fasting tests, performed without medication or i.v.-glucose, were investigated in children with a clinical diagnosis of CHI, or idiopathic ketotic hypoglycemia (IKH). The CHI diagnosis was either clinical or by the alternative, p-insulin-free criteria; hypoglycemia plus disease-causing genetic mutations and/or CHI-compatible pancreatic histopathology. We included diagnostic p-insulin samples with simultaneous p-glucose <3.2 mmol/L and used a sensitive insulin assay (Cobas e411 immunoassay analyzer; lower detection limit 1.2 pmol/L; normal range 15.1–147.1 pmol/L). Receiver operating characteristics area under the curve (ROC AUC) values and optimal cut-offs were analyzed for the performance of p-insulin to diagnose CHI.ResultsIn 61 CHI patients, the median (range) p-insulin was 76.5 (17–644) pmol/L compared to 1.5 (1.5–7.7) pmol/L in IKH patients (n=15). The ROC AUC was 1.0 for the diagnosis of CHI defined both by the clinical diagnosis (n=61) and by alternative criteria (n=57). The optimal p-insulin cut-offs were 12.3 pmol/L, and 10.6 pmol/L, at p-glucose <3.2 mmol/L (n=61), and <3.0 mmol/L (n=49), respectively.ConclusionsThe sensitive insulin assay performed excellent in diagnosing CHI with optimal p-insulin cut-offs at 12.3 pmol/L (2.0 mU/L), and 10.6 pmol/L (1.8 mU/L), at p-glucose <3.2 mmol/L, and <3.0 mmol/L, respectively. A sensitive insulin assay may serve to simplify the diagnosis of CHI.https://www.frontiersin.org/articles/10.3389/fendo.2020.614993/fullhypoglycemiacongenital hyperinsulinismchildrendiagnostic performanceimmunoassays
collection DOAJ
language English
format Article
sources DOAJ
author Julie Siersbæk
Julie Siersbæk
Annette Rønholt Larsen
Annette Rønholt Larsen
Mads Nybo
Henrik Thybo Christesen
Henrik Thybo Christesen
Henrik Thybo Christesen
spellingShingle Julie Siersbæk
Julie Siersbæk
Annette Rønholt Larsen
Annette Rønholt Larsen
Mads Nybo
Henrik Thybo Christesen
Henrik Thybo Christesen
Henrik Thybo Christesen
A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism
Frontiers in Endocrinology
hypoglycemia
congenital hyperinsulinism
children
diagnostic performance
immunoassays
author_facet Julie Siersbæk
Julie Siersbæk
Annette Rønholt Larsen
Annette Rønholt Larsen
Mads Nybo
Henrik Thybo Christesen
Henrik Thybo Christesen
Henrik Thybo Christesen
author_sort Julie Siersbæk
title A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism
title_short A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism
title_full A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism
title_fullStr A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism
title_full_unstemmed A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism
title_sort sensitive plasma insulin immunoassay to establish the diagnosis of congenital hyperinsulinism
publisher Frontiers Media S.A.
series Frontiers in Endocrinology
issn 1664-2392
publishDate 2021-02-01
description BackgroundThe diagnosis of congenital hyperinsulinism (CHI) may be hampered by a plasma (p-) insulin detection limit of 12–18 pmol/L (2–3 mU/L).ObjectiveTo evaluate the diagnostic performance of a sensitive insulin immunoassay and to find the optimal p-insulin cut-off for the diagnosis of CHI.MethodsDiagnostic fasting tests, performed without medication or i.v.-glucose, were investigated in children with a clinical diagnosis of CHI, or idiopathic ketotic hypoglycemia (IKH). The CHI diagnosis was either clinical or by the alternative, p-insulin-free criteria; hypoglycemia plus disease-causing genetic mutations and/or CHI-compatible pancreatic histopathology. We included diagnostic p-insulin samples with simultaneous p-glucose <3.2 mmol/L and used a sensitive insulin assay (Cobas e411 immunoassay analyzer; lower detection limit 1.2 pmol/L; normal range 15.1–147.1 pmol/L). Receiver operating characteristics area under the curve (ROC AUC) values and optimal cut-offs were analyzed for the performance of p-insulin to diagnose CHI.ResultsIn 61 CHI patients, the median (range) p-insulin was 76.5 (17–644) pmol/L compared to 1.5 (1.5–7.7) pmol/L in IKH patients (n=15). The ROC AUC was 1.0 for the diagnosis of CHI defined both by the clinical diagnosis (n=61) and by alternative criteria (n=57). The optimal p-insulin cut-offs were 12.3 pmol/L, and 10.6 pmol/L, at p-glucose <3.2 mmol/L (n=61), and <3.0 mmol/L (n=49), respectively.ConclusionsThe sensitive insulin assay performed excellent in diagnosing CHI with optimal p-insulin cut-offs at 12.3 pmol/L (2.0 mU/L), and 10.6 pmol/L (1.8 mU/L), at p-glucose <3.2 mmol/L, and <3.0 mmol/L, respectively. A sensitive insulin assay may serve to simplify the diagnosis of CHI.
topic hypoglycemia
congenital hyperinsulinism
children
diagnostic performance
immunoassays
url https://www.frontiersin.org/articles/10.3389/fendo.2020.614993/full
work_keys_str_mv AT juliesiersbæk asensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT juliesiersbæk asensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT annetterønholtlarsen asensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT annetterønholtlarsen asensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT madsnybo asensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT henrikthybochristesen asensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT henrikthybochristesen asensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT henrikthybochristesen asensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT juliesiersbæk sensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT juliesiersbæk sensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT annetterønholtlarsen sensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT annetterønholtlarsen sensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT madsnybo sensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT henrikthybochristesen sensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT henrikthybochristesen sensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
AT henrikthybochristesen sensitiveplasmainsulinimmunoassaytoestablishthediagnosisofcongenitalhyperinsulinism
_version_ 1724261616612016128